Correlation Between Mereo BioPharma and Verrica Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and Verrica Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and Verrica Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and Verrica Pharmaceuticals, you can compare the effects of market volatilities on Mereo BioPharma and Verrica Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of Verrica Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and Verrica Pharmaceuticals.
Diversification Opportunities for Mereo BioPharma and Verrica Pharmaceuticals
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Mereo and Verrica is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and Verrica Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verrica Pharmaceuticals and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with Verrica Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verrica Pharmaceuticals has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and Verrica Pharmaceuticals go up and down completely randomly.
Pair Corralation between Mereo BioPharma and Verrica Pharmaceuticals
Given the investment horizon of 90 days Mereo BioPharma Group is expected to generate 0.72 times more return on investment than Verrica Pharmaceuticals. However, Mereo BioPharma Group is 1.39 times less risky than Verrica Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Verrica Pharmaceuticals is currently generating about -0.04 per unit of risk. If you would invest 104.00 in Mereo BioPharma Group on November 2, 2024 and sell it today you would earn a total of 201.00 from holding Mereo BioPharma Group or generate 193.27% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mereo BioPharma Group vs. Verrica Pharmaceuticals
Performance |
| Timeline |
| Mereo BioPharma Group |
| Verrica Pharmaceuticals |
Mereo BioPharma and Verrica Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mereo BioPharma and Verrica Pharmaceuticals
The main advantage of trading using opposite Mereo BioPharma and Verrica Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, Verrica Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verrica Pharmaceuticals will offset losses from the drop in Verrica Pharmaceuticals' long position.| Mereo BioPharma vs. Terns Pharmaceuticals | Mereo BioPharma vs. PDS Biotechnology Corp | Mereo BioPharma vs. Inozyme Pharma | Mereo BioPharma vs. Hookipa Pharma |
| Verrica Pharmaceuticals vs. Inventiva Sa | Verrica Pharmaceuticals vs. Edgewise Therapeutics | Verrica Pharmaceuticals vs. Vigil Neuroscience | Verrica Pharmaceuticals vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |